Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals

Arthritis & Rheumatology(2021)10.1002/art.41800Source: DataRank Database

Risk of COVID‐19 in Rheumatoid Arthritis: A National Veterans Affairs Matched Cohort Study in At‐Risk Individuals is a research paper published in Arthritis & Rheumatology (2021). On theSindex it has a DataRank of 5.6. It has been cited 127 times, with 115 citing works in its 1-hop citation network.

N/A

5.6DataRank · unranked

Scored on demand from live citation data

Open Access127 citations · 115 citing works in its network

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (12 grants)OA: bronzeTopics (28)Linked Datasets (8)DataCite Reuse (8)IDs (PubMed, PMC)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 13%Citation Network 87%

Base Score Contribution

0.728

From this paper's citation signal

Citation Network Contribution

4.9

From 95 citing papers with measurable signal

Learn more about DataRank methodology →

Top 5 citers driving the network score

Ranked by each citer's contribution to N(p) — log1p(C_q) divided by its reference count — out of 115 citers.

Increased Risk of COVID‐19 in Patients With Rheumatoid Arthritis: A General Population‐Based Cohort Study
Arthritis Care & Research202128 citations15 referencesContributes 0.224
Factors associated with COVID-19 and its outcome in patients with rheumatoid arthritis
Clinical Rheumatology202117 citations13 referencesContributes 0.222
Factors Associated With Hospitalization and Death After COVID‐19 Diagnosis Among Patients With Rheumatic Disease: An Analysis of Veterans Affairs Data
ACR Open Rheumatology20216 citations10 referencesContributes 0.195
Long-term use of immunosuppressive medicines and in-hospital COVID-19 outcomes: a retrospective cohort study using data from the National COVID Cohort Collaborative
The Lancet Rheumatology2021134 citations30 referencesContributes 0.164
Rituximab is associated with worse COVID-19 outcomes in patients with rheumatoid arthritis: A retrospective, nationally sampled cohort study from the U.S. National COVID Cohort Collaborative (N3C)
Seminars in Arthritis and Rheumatism202247 citations26 referencesContributes 0.149

Authors (9)

Punyasha Roul,Yangyuna Yang,André C. Kalil ORCID,Kaleb Michaud ORCID,Geoffrey M. Thiele ORCID

Live enrichment

PubMed:33955209 PMC:PMC8239709

U.S. Department of Veterans Affairs

Grant: IK2‐CX‐002203

U.S. Department of Veterans Affairs

Grant: I01‐BX‐004660

U.S. Department of Veterans Affairs

Grant: I01‐CX‐001703

National Institute of General Medical Sciences

Grant: U54‐GM‐115458

US Department of Veterans Affairs

Grant: I01-BX-004660

US Department of Veterans Affairs

Grant: I01-CX-001703

US Department of Veterans Affairs

Grant: IK2-CX-002203

NIGMS NIH HHS

Grant: U54-GM-115458

CSRD VA

Grant: IK2 CX002203

National Institutes of Health

Grant: 3U54GM115458-07S2

Great Plains IDeA-CTR

Rheumatology Research Foundation

University of Nebraska College of Medicine

bronzeLicense: Wiley Online Library User Agreement

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/art.41800

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/art.41800

publisherhttps://acrjournals.onlinelibrary.wiley.com/doi/pdf/10.1002/art.41800

https://doi.org/10.1002/art.41800

https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/art.41800

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansArthritis, RheumatoidHospitalizationSeverity of Illness IndexRisk AssessmentRetrospective StudiesCohort StudiesAgedMiddle AgedFemaleMaleVeterans HealthCOVID-19

Keywords

MaleCOVID-19Veterans HealthMiddle AgedRisk AssessmentSeverity of Illness IndexArthritis, RheumatoidCohort StudiesHospitalizationHumansFemaleAgedRetrospective Studies

Sustainable Development Goals

SDG 3: 3. Good health

Additional file 2 of SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis

10.6084/m9.figshare.22615381.v1figshare

Additional file 2 of SARS-CoV-2 spike protein promotes inflammatory cytokine activation and aggravates rheumatoid arthritis

10.6084/m9.figshare.22615381figshare

Additional file 1 of Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

10.6084/m9.figshare.26605015.v1figshare

10.6084/m9.figshare.26605015figshare

Additional file 2 of Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

10.6084/m9.figshare.26605018.v1figshare

10.6084/m9.figshare.26605018figshare

Additional file 3 of Comparison of anti-spike IgG, anti-spike IgA levels and neutralizing antibody activity induced by CoronaVac and BNT162b2 vaccines in patients with inflammatory rheumatic diseases receiving immunosuppressive therapy

10.6084/m9.figshare.26605021.v1figshare

10.6084/m9.figshare.26605021figshare